Posted BY: Wyatt | NwoReport
(Natural News) The FDA recently expanded its Emergency Use Authorization (EUA) for the monkeypox vaccine, allowing it to be used in children under 18 who are considered to have a "high risk" of infection.
Before the updated EUA, "numerous" children had been given the vaccine via a special permission process despite not being authorized or approved for children, the FDA confirmed. The median age of people being infected by the virus is 35, and very few cases involving children have been reported so far in the U.S.
Are there really that many children at risk of contracting a disease that is primarily spread through male homosexual activity? Some have made the argument that some children are exposed to the disease because they are being abused, but wouldn't a better solution be to remove these children from the abusive situations that are putting them at risk?
According to the CDC, children who have a higher risk for severe monkeypox are those who have an abnormal infection involving their face, genitals or eyes; are under eight years of age; have a history of skin conditions such as psoriasis or eczema; or have an immunocompromising disease. Is every child who got a COVID-19 vaccine now at a higher risk of monkeypox and many other illnesses thanks to its weakening effect on their immune systems?
The EUA also expanded the vaccine options for the disease to include administering the Jynneos smallpox vaccine via intradermal injection. This means it can be injected between the layers of the skin instead of underneath it. This would increase the number of available doses fivefold as the method only uses a fraction of the dose while allegedly offering the same protection. The current 441,000 available doses could be stretched to 2.2 million using the approach.
Read More
No comments:
Post a Comment